Acceptability of a new 4-in-1 Abacavir/Lamivudine/Lopinavir/Ritonavir paediatric fixed-dose combination: the caregiver–child dyads’ perspective

BACKGROUND: Worldwide, 1.7 million children younger than 15 years were living with HIV in 2021. Only 52% of them had access to antiretrovirals (ARVs). Lack of age-appropriate ARV formulations (i.e. easy to swallow for young infants, acceptable taste) remains the main obstacle to the access to ARVs....

Descripción completa

Detalles Bibliográficos
Autores principales: Rotsaert, Anke, Ogara, Collin, Mwanga-Amumpaire, Juliet, Kekitiinwa, Adeodata R., Musiime, Victor, Najjingo, Elizabeth, Kisitu, Grace P., Nazzinda, Rashidah, Nambi, Esther, Lee, Janice, Diallo, Mariama, Kyomuhendo, Flavia, Waweru, Moses, Andrieux-Meyer, Isabelle, Nöstlinger, Christiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
INTEREST 2022: New perspectives in HIV treatment, pathogenesis and prevention in Africa
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031622/
https://www.ncbi.nlm.nih.gov/pubmed/36968554
http://dx.doi.org/10.1177/20499361231159993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031622/
https://www.ncbi.nlm.nih.gov/pubmed/36968554
http://dx.doi.org/10.1177/20499361231159993

Ejemplares similares